EN
FR
Contact Us
Donate

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

News

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma image_name_-_follicular-lymphoma-4-ln022-1-4

News

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma

Spaghetti sauce for lymphoma

Events News

Spaghetti sauce for lymphoma

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

News

CANCER PATIENTS CELEBRATE NEW PROGRAM FOR TAKE-HOME CANCER MEDICATIONS IN NOVA SCOTIA

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

News

Hodgkin Lymphoma Patient Survey: Experience with Nivolumab (Opdivo)

Count Down to World Lymphoma Awareness Day

Events News

Count Down to World Lymphoma Awareness Day

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

News

Hodgkin Lymphoma Patient Survey: Experience with Brentuximab-vedotin (Adcetris)

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

News

Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma at Increased Risk of Relapse or Progression

Lymphoma Canada Awareness Day at Queen’s Park

Events News

Lymphoma Canada Awareness Day at Queen’s Park

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

News

New Targeted Therapy Safe and Effective in Refractory Non-Hodgkin’s Lymphoma Patients

Search

Are you a patient?

Get Informed

Are you a healthcare professional?

See Resources

Contact Us

Lymphoma Canada
6860 Century Avenue, Suite 202
Mississauga, ON L5N 2W5
Telephone 905.858.5967
Toll Free: 1.866.659.5556
General inquiries: info@lymphoma.ca
Charitable Number: 873461040RR0001

Donate

With your support, no one will have to face lymphoma alone. You can make a difference!
Donate

Careers

Join Our Mailing List

First Name *

Last Name *

Email Address *

Preferred Language

English
French

YouTube
X
Facebook
Instagram
LinkedIn

Donate
Accessibility
Privacy Policy
Terms of Use

Close Menu

Lymphoma
Patient Experience
Resources
News & Events
Get Involved
Ways to Give
About Us
Know Your Nodes

EN
FR
Contact Us
Donate

News

Obinutuzumab Reduces Risk of Disease Progression in Follicular Lymphoma

Search

Recent Posts

Are you a patient?

Are you a healthcare professional?

Contact Us

Donate

Join Our Mailing List